Cargando…

272. Clinical Outcomes with Continuation of Combination Antibiotic Therapy versus De-escalation to Monotherapy for Patients with MRSA Bacteremia

BACKGROUND: Persistent methicillin-resistant Staphylococcus aureus (MRSA) bacteremia is associated with increased morbidity and mortality. Previous studies have demonstrated lower mortality with combination therapy (CT) compared to monotherapy (MT) for MRSA bacteremia; however, there is a lack of ev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nichols, Courtney, Sobhanie, Mahdee, Wardlow, Lynn, Coe, Kelci E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777132/ http://dx.doi.org/10.1093/ofid/ofaa439.316

Ejemplares similares

Clinical Outcomes With Definitive Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia With Retained Daptomycin and Ceftaroline Combination Therapy vs De-escalation to Monotherapy With Vancomycin, Daptomycin, or Ceftaroline
por: Nichols, Courtney N, et al.
Publicado: (2021)

600. The Effect of Medication-Assisted Treatment on Completion Rates of Outpatient Parenteral Antibiotic Therapy
por: Greco, Christian S, et al.
Publicado: (2021)

1900. Disseminated and Extrapulmonary Nontuberculous Mycobacteria (NTM): Disease Management, Adverse Treatment Reactions, and Outcomes
por: Wang, Heather, et al.
Publicado: (2023)

1484. Impact of Combination Vs. Monotherapy on Clinical Outcomes Associated with Stenotrophomonas maltophilia Pneumonia
por: Shah, Megan, et al.
Publicado: (2018)

367. Clinical Characteristics and Outcomes in Patients with Pneumonia secondary to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
por: Nichols, Courtney, et al.
Publicado: (2020)

1239. Ceftaroline versus Vancomycin as First-Line Therapy for MRSA Bacteremia
por: Kamath, Meghan, et al.
Publicado: (2021)

318. Description of Patients Readmitted within 30 Days from COVID-19 Hospitalization
por: Al-Saadi, Mahmoud, et al.
Publicado: (2021)

59. Impact of Pharmacist-Led De-Escalation of MRSA Therapy Using MRSA Nasal PCR
por: Salvatus, Marc, et al.
Publicado: (2021)

1036. Clinical impact of an antibiotic time out initiative at an academic medical center
por: Taylor, Amy P, et al.
Publicado: (2019)

1215. The Impact of MRSA Nasal PCR on Antibiotic De-escalation
por: Silverman, Adam, et al.
Publicado: (2023)

535. Comparison of Outcomes in Patients Positive for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection After Monoclonal Antibody Therapy (MAT) with Bamlamivimab or Casirivimab-Imdevimab
por: Nichols, Courtney, et al.
Publicado: (2021)

553. Outcomes in Patients Positive for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection After Treatment with Monoclonal Antibody Therapy (MAT) in the Outpatient Setting
por: Nichols, Courtney, et al.
Publicado: (2021)

1357. Patterns of Extragenital Gonorrhea and Chlamydia Testing at a Community-Based Academic Emergency Department in Columbus, Ohio
por: Magaña, Francisco M, et al.
Publicado: (2021)

272 Characteristics of USA500/Iberian Methicillin-Resistant Staphylococcus aureus (MRSA) Invasive Disease
por: Melendez, Andre G., et al.
Publicado: (2014)

2413. Drug Use Associated vs Non-Drug Use Associated Endocarditis in an Academic Center from 2012-2017
por: Sobhanie, Mohammad Mahdee, et al.
Publicado: (2023)

480. Redefining the Epidemiologic Profile of Histoplasmosis from 2011 to 2021 in Central Ohio
por: Hofmann, JustIn, et al.
Publicado: (2022)

204. Clinical Outcomes with Ceftaroline Monotherapy versus Daptomycin-Ceftaroline Combination Therapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Andonie, Gabriela, et al.
Publicado: (2021)

2265. Clinical Outcomes with Single vs. Combination Antibiotic Therapy in the Treatment of Burkholderia cepacia complex Bacteremia and Pneumonia
por: George, G Taylor A, et al.
Publicado: (2019)

197. Infective Endocarditis Over a Five-Year Period in an Academic Teaching Center: The Validity of ICD Codes vs. Manual Chart Review
por: Haden, Michael, et al.
Publicado: (2019)

2948. Pediatric Clinical Outcomes of MRSA PCR Utilization for Anti-MRSA De-escalation
por: Demirhan, Salih, et al.
Publicado: (2023)

562. Reducing MRSA Bacteremia in Adult Patients through MRSA Decolonization Bundle
por: Goldman, Erin, et al.
Publicado: (2019)

722. Effectiveness of Fidaxomicin versus Oral Vancomycin in the Treatment of Recurrent Clostridioides difficile
por: Rinaldi, Alyssa, et al.
Publicado: (2020)

Predicting Risk for Death from MRSA Bacteremia
por: Pastagia, Mina, et al.
Publicado: (2012)

Colistin monotherapy versus therapy combination
por: Charra, B, et al.
Publicado: (2010)

177. Clinical Outcomes of Daptomycin vs. Anti-Staphylococcal β-Lactams in Definitive Treatment of Methicillin-Susceptible Staphylococcus aureus (MSSA) Bloodstream Infections
por: Agnello, Sydney, et al.
Publicado: (2019)

MRSA in the bursa: an unusual complication of MRSA bacteremia causing bilateral acromioclavicular septic arthritis
por: Rodriguez-Quick, Victoria A., et al.
Publicado: (2022)

Selective decontamination using antibiotics in ICU patients: counterfactual protection versus contextual hazard toward bacteremia incidences
por: Hurley, JC
Publicado: (2014)

Health Tract, No. 272: Typhoid
Publicado: (1868)

1624. Real World Experience with Daptomycin (DAP) and Ceftaroline (CPT) Combination Therapy for Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia
por: Zidaru, Andrei, et al.
Publicado: (2020)

Antibiotic costs in bacteremic and nonbacteremic patients treated with the de-escalation approach
por: Evodia, E, et al.
Publicado: (2008)

De-escalation of empiric antibiotic therapy in sepsis - an indian observational study
por: Jakkinaboina, S, et al.
Publicado: (2015)

1804. Impact of Susceptibility Testing Method on Antibiotic Selection for Methicillin-Resistant Staphylococcus Aureus (MRSA) Bacteremia
por: Bhatt, Mahesh, et al.
Publicado: (2018)

2573. The Use of MRSA PCR for De-escalation of Anti-MRSA therapy for CAP and HAP at a Community Hospital: a Quality Improvement Analysis for Antibiotic Stewardship
por: Browne, Angelina M, et al.
Publicado: (2023)

Continuation Versus De-escalation of Broad-Spectrum Antibiotic Therapy in Critically Ill COVID-19 Patients
por: Aldardeer, Namareq F., et al.
Publicado: (2023)

1471. Evaluation of Antibiotic De-escalation in Post Cardiac Arrest Patients with Culture-Negative versus Culture-Positive Aspiration Pneumonia
por: Herzig, Natasha R, et al.
Publicado: (2020)

PK/PD modeling supports the dose-escalation decision in VIKING
por: Lovern, M, et al.
Publicado: (2010)

Assessment of risk factors in the development of MRSA infection at Gülhane Military Medical Faculty Education Hospital and the role of antibiotic use on the development of MRSA infection
por: Gunal, E, et al.
Publicado: (2011)

A272 EVIDENCE OF SEX DIFFERENCES IMPACTING PAIN SIGNALING BY LUMINAL MEDIATORS IN IRRITABLE BOWEL SYNDROME
por: Ables, S, et al.
Publicado: (2023)

P688: ASC2ESCALATE: A US PHASE 2, OPEN-LABEL, SINGLE-ARM, DOSE-ESCALATION STUDY OF ASCIMINIB MONOTHERAPY IN 2ND-LINE (2L) TREATMENT OF PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP)
por: Atallah, Ehab, et al.
Publicado: (2023)

1489. Safety and Performance of a Pharmacist-Driven Nasal MRSA PCR Protocol for De-escalation of Empiric Vancomycin for Suspected Pneumonia at an Academic Medical Center
por: Meng, Lina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_api483dtt07hgbmq51c0p8rs4a